76 related articles for article (PubMed ID: 15160842)
21. X-ray crystallographic study of an HIV-1 fusion inhibitor with the gp41 S138A substitution.
Watabe T; Terakawa Y; Watanabe K; Ohno H; Nakano H; Nakatsu T; Kato H; Izumi K; Kodama E; Matsuoka M; Kitaura K; Oishi S; Fujii N
J Mol Biol; 2009 Sep; 392(3):657-65. PubMed ID: 19616557
[TBL] [Abstract][Full Text] [Related]
22. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents.
Conlon JM; Al-Ghaferi N; Abraham B; Leprince J
Methods; 2007 Aug; 42(4):349-57. PubMed ID: 17560323
[TBL] [Abstract][Full Text] [Related]
23. Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Shin SY; Lee MK; Kim KL; Hahm KS
J Pept Res; 1997 Oct; 50(4):279-85. PubMed ID: 9352466
[TBL] [Abstract][Full Text] [Related]
24. Hematological and antifungal properties of temporin A and a cecropin A-temporin A hybrid.
Wade D; Silveira A; Rollins-Smith L; Bergman T; Silberring J; Lankinen H
Acta Biochim Pol; 2001; 48(4):1185-9. PubMed ID: 11995990
[TBL] [Abstract][Full Text] [Related]
25. Biological activities of cecropin B-thanatin hybrid peptides.
Hongbiao W; Baolong N; Mengkui X; Lihua H; Weifeng S; Zhiqi M
J Pept Res; 2005 Dec; 66(6):382-6. PubMed ID: 16316454
[TBL] [Abstract][Full Text] [Related]
26. Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons.
Cerovský V; Hovorka O; Cvacka J; Voburka Z; Bednárová L; Borovicková L; Slaninová J; Fucík V
Chembiochem; 2008 Nov; 9(17):2815-21. PubMed ID: 18942691
[TBL] [Abstract][Full Text] [Related]
27. Hydrophobic substitutions in the first residue of the CRAC segment of the gp41 protein of HIV.
Vishwanathan SA; Thomas A; Brasseur R; Epand RF; Hunter E; Epand RM
Biochemistry; 2008 Jan; 47(1):124-30. PubMed ID: 18081318
[TBL] [Abstract][Full Text] [Related]
28. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.
McFadden K; Cocklin S; Gopi H; Baxter S; Ajith S; Mahmood N; Shattock R; Chaiken I
Proteins; 2007 May; 67(3):617-29. PubMed ID: 17348010
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
Chan WE; Chen SS
Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
[TBL] [Abstract][Full Text] [Related]
31. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
[TBL] [Abstract][Full Text] [Related]
32. A study of the coevolutionary patterns operating within the env gene of the HIV-1 group M subtypes.
Travers SA; Tully DC; McCormack GP; Fares MA
Mol Biol Evol; 2007 Dec; 24(12):2787-801. PubMed ID: 17921487
[TBL] [Abstract][Full Text] [Related]
33. Design and optimisation of potent gp120-CD4 inhibitors.
Tran TD; Adam FM; Calo F; Fenwick DR; Fok-Seang J; Gardner I; Hay DA; Perros M; Rawal J; Middleton DS; Parkinson T; Pickford C; Platts M; Randall A; Stephenson PT; Vuong H; Williams DH
Bioorg Med Chem Lett; 2009 Sep; 19(17):5250-5. PubMed ID: 19632839
[TBL] [Abstract][Full Text] [Related]
34. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
[TBL] [Abstract][Full Text] [Related]
35. Properties and structure-activity studies of cyclic beta-hairpin peptidomimetics based on the cationic antimicrobial peptide protegrin I.
Robinson JA; Shankaramma SC; Jetter P; Kienzl U; Schwendener RA; Vrijbloed JW; Obrecht D
Bioorg Med Chem; 2005 Mar; 13(6):2055-64. PubMed ID: 15727859
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial synergism of novel antibiotic peptides with chloramphenicol.
Park Y; Kim HJ; Hahm KS
Biochem Biophys Res Commun; 2004 Aug; 321(1):109-15. PubMed ID: 15358222
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope.
Molina L; Grimaldi M; Robert-Hebmann V; Espert L; Varbanov M; Devaux C; Granier C; Biard-Piechaczyk M
Proteomics; 2007 Sep; 7(17):3116-30. PubMed ID: 17676665
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction.
Williams DH; Adam F; Fenwick DR; Fok-Seang J; Gardner I; Hay D; Jaiessh R; Middleton DS; Mowbray CE; Parkinson T; Perros M; Pickford C; Platts M; Randall A; Siddle D; Stephenson PT; Tran TD; Vuong H
Bioorg Med Chem Lett; 2009 Sep; 19(17):5246-9. PubMed ID: 19620004
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and secretory expression of hybrid antimicrobial peptide CecA-mag and its mutants in Pichia pastoris.
Wang X; Zhu M; Zhang A; Yang F; Chen P
Exp Biol Med (Maywood); 2012 Mar; 237(3):312-7. PubMed ID: 22378824
[TBL] [Abstract][Full Text] [Related]
40. Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action.
Shin S; Kim JK; Lee JY; Jung KW; Hwang JS; Lee J; Lee DG; Kim I; Shin SY; Kim Y
J Pept Sci; 2009 Sep; 15(9):559-68. PubMed ID: 19598182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
